Ketogenic metabolic therapy for chronic kidney disease – the pro part

ABSTRACT Ketogenic Metabolic Therapy (KMT) is a medical nutrition therapy to address certain health and disease conditions. It is increasingly used for many non-communicable diseases that are rooted in abnormal metabolic health. Since chronic kidney disease (CKD) is commonly caused by overnutrition leading to hyperglycemia, insulin resistance and diabetes mellitus, the carbohydrate restriction inherent in KMT may offer a therapeutic option. Numerous studies have found that various forms of KMT are safe for individuals with CKD and may lead to improvement of renal function. This is in contrast to the current standard pharmacological approach to CKD which only slows the relentless progression towards renal failure. Kidney care providers including physicians and dietitians are usually not aware of non-standard dietary interventions, including KMT, and often antagonize KMT due to common misconceptions and uncertainty about the underlying science including the common misconception that KMT must involve high protein or meat consumption. This review article discusses the rationales for using KMT, including plant-dominant KMT, for treatment of CKD, clarifies common misconceptions, summarizes the results of clinical studies, and discusses why KMT can emerge as an effective Medical Nutrition Therapy (MNT) to consider for patients with kidney disease. KMT, including its plant-dominant versions, can expand a practitioner's kidney health toolbox, and will likely become a first-line therapy for CKD in certain CKD associated conditions such as obesity, metabolic syndrome and polycystic kidney disease.